Kristi Rosa

home / authors / kristi-rosa

Articles

DTx Receives FDA’s Breakthrough Device Designation for Anxiety and Depression Symptoms Associated With Cancer

DTx Receives FDA’s Breakthrough Device Designation for Anxiety and Depression Symptoms Associated With Cancer

January 28th 2022

The specialized device is being studied for patients receiving inpatient care for acute myeloid leukemia.

Latest Updated Articles

Mini Quiz: Treatment for Pedophilia?

Published: March 19th 2021 | Updated: July 16th 2025

Mini Quiz: Treatment for Pedophilia?

PsychQuiz: Tardive Dyskinesia Risk Factors

Published: April 16th 2021 | Updated: July 16th 2025

PsychQuiz: Tardive Dyskinesia Risk Factors

Dee/Adobe Stock

Published: July 12th 2025 | Updated: July 16th 2025

Toward a Muscarinic Agent Solution for the Presynaptic Dopamine Problem in Schizophrenia

sebra/Adobe Stock

Published: July 12th 2025 | Updated: July 16th 2025

Treatment-Resistant Depression and Well-Rounded Care, With Alejandro Alva at Southern California Psychiatry

Mini Quiz: Coronavirus Outbreak and Mental Illness

Published: March 11th 2020 | Updated: July 16th 2025

Mini Quiz: Coronavirus Outbreak and Mental Illness

crizzystudio/Adobe Stock

Published: July 12th 2025 | Updated: July 16th 2025

Well-Rounded Examination for Treatment of Tardive Dyskinesia

Terms and Conditions

Do Not Sell My Personal Information

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

© 2025 MJH Life Sciences

All rights reserved.